NOVARTIS NNOVARTIS NNOVARTIS N

NOVARTIS N

No trades
See on Supercharts

Price target

100.270.00 0.00%
The 20 analysts offering 1 year price forecasts for NOVN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 27 analysts giving stock ratings to NOVN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

NOVN EPS for the last quarter is 1.62 CHF despite the estimation of 1.51 CHF. In the next quarter EPS is expected to reach 1.67 CHF. Track more of NOVARTIS N financials and stay on top of what is up with the company.
In the next quarter NOVARTIS N revenue is expected to reach ‪11.22 B‬ CHF. Check out NOVARTIS N revenue and earnings and make informed decisions.
According to analysts, NOVN price target is 100.27 CHF with a max estimate of 119.58 CHF and a min estimate of 74.33 CHF. Check if this forecast comes true in a year, meanwhile keep track of the current situation with NOVN news and stock market news.
We've gathered opinions of 27 analysts rating NOVN stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.